Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

KORU Medical Systems (KRMD) Research & Development (2020 - 2025)

KORU Medical Systems has reported Research & Development over the past 11 years, most recently at $1.1 million for Q4 2025.

  • Quarterly results put Research & Development at $1.1 million for Q4 2025, up 2.74% from a year ago — trailing twelve months through Dec 2025 was $4.4 million (down 16.56% YoY), and the annual figure for FY2025 was $4.4 million, down 16.56%.
  • Research & Development for Q4 2025 was $1.1 million at KORU Medical Systems, up from $933107.0 in the prior quarter.
  • Over the last five years, Research & Development for KRMD hit a ceiling of $1.6 million in Q4 2022 and a floor of $336841.0 in Q1 2021.
  • Median Research & Development over the past 5 years was $1.1 million (2022), compared with a mean of $1.1 million.
  • Biggest five-year swings in Research & Development: soared 240.92% in 2022 and later crashed 39.17% in 2025.
  • KORU Medical Systems' Research & Development stood at $949930.0 in 2021, then soared by 72.85% to $1.6 million in 2022, then decreased by 21.59% to $1.3 million in 2023, then dropped by 13.46% to $1.1 million in 2024, then increased by 2.74% to $1.1 million in 2025.
  • The last three reported values for Research & Development were $1.1 million (Q4 2025), $933107.0 (Q3 2025), and $1.2 million (Q2 2025) per Business Quant data.